• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • 2026 Election
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • Trump Administration
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • 2026 Election
  • Trump Administration
  • IN FOCUS
  • Commentary
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Tags Pharmaceutical Industry

    Tag: Pharmaceutical Industry

    On Tuesday, the Supreme Court scrapped the provocation rule because of its inconsistency with existing court precedent. (AP Photo/J. Scott Applewhite)
    Immigration

    Supreme Court tackles due process during its last week of arguments

    Ryan Lovelace -
    April 23, 2017 4:00 am
    0
    Embattled drugmaker leaves top industry group
    Healthcare

    Embattled drugmaker leaves top industry group

    Robert King -
    April 21, 2017 4:05 pm
    0
    In short, many of these pharmacies are outright scams. (iStock)
    Op-Eds

    Importing drugs from Canada is a dangerous game

    Charlie Cichon -
    April 12, 2017 11:00 am
    0
    President Trump's pick to lead the FDA dodged a key question on whether he will adopt reforms Trump touted on the campaign trail to lower high drug prices. (AP Photo/Brian Branch-Price)
    Healthcare

    FDA pick Scott Gottlieb dodges key question on drug pricing

    Robert King -
    April 5, 2017 4:21 pm
    0
    Susan Sarandon narrates the Tylenol's television advertisements and is paid by parent company Johnson & Johnson. (Photo by Willy Sanjuan/Invision/AP)
    Beltway Confidential

    Anti-lobbying Susan Sarandon works for Big Pharma

    Emily Jashinsky -
    March 22, 2017 7:02 pm
    0
    5 drug policy positions held by Trump’s FDA pick, Dr. Scott Gottlieb
    Healthcare

    5 drug policy positions held by Trump’s FDA pick, Dr. Scott Gottlieb

    Paige Winfield Cunningham -
    March 20, 2017 12:01 am
    0
    Other countries don't care to operate with transparent prices sending signals to markets. (AP Photo/Pat Roque)
    Beltway Confidential

    In the Obamacare debate, drug ‘importation’ is another way of saying ‘government price controls’

    Ryan Ellis -
    March 15, 2017 12:00 am
    0
    Rep. Elijah Cummings, D-Md., said he is planning to meet with President Trump to discuss how to fight high drug prices.
    Healthcare

    Top House Oversight Democrat to meet with Trump Wednesday

    Gabby Morrongiello -
    March 7, 2017 5:05 pm
    0
    President Trump promised the next phases of the Republican healthcare plan would make it legal for healthcare to be sold across state lines. (AP Photo/Pablo Martinez Monsivais)
    Healthcare

    Trump promises more healthcare proposals to make insurance cheaper

    Kyle Feldscher -
    March 7, 2017 2:01 pm
    0
    President Trump signed into law the FDA Reauthorization Act of 2017 on Friday. It reauthorizes a program in which drug and device makers pay the FDA a fee for every new product application, and the agency uses that money to hire more people and speed up approvals. (AP Photo/Andrew Harnik, File)
    Healthcare

    Trump aims to take on ‘slow’ FDA

    Robert King -
    March 1, 2017 2:40 am
    0
    1...111112113...157Page 112 of 157
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter
    • © Copyright 2026. Washington Examiner. All Rights Reserved.